Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-05-24
1996-12-03
Lilling, Herbert J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
424 7808, 424 7832, 4352402, 436501, 436548, 436811, 549510, A61K 31335, A01N 4302
Patent
active
055808980
ABSTRACT:
A method of stabilizing microtubules which are destabilized due to insufficient levels of normal human tau protein is disclosed. The method comprises the steps of contacting a microtubule that is destablizing due to a deficiency in normal tau protein with an amount of taxol sufficient to stabilize microtubules.
REFERENCES:
patent: 5362831 (1994-11-01), Mongelli et al.
patent: 5380751 (1995-01-01), Chen et al.
Everitte-Voegelein et al "J. Nat Prod" vol. 50 No. 1 Jan.-Feb. 1987 Taxol & Derivatives: A Biogenetic Hypothesis pp. 9-18.
Bramblett et al., "Regions with Abundant Neurofibrillary Pathology in Human Brain Exhibit a Selective Reduction in Levels of Binding-Competent .tau. and Accumulation of Abnormal .tau.-Isoforms (A68 Proteins)" Lab Invest. 66 212-222, (1992).
Bramblett et al. "The Abnormal Phosphorylation of Tau at Ser.sup.396 in Alzheimer's Disease Recpaitulates Phosphorylation During Development and Contributes to Reduced Microtubule Binding", Neuron 10: 1089-1099 (1993).
Butner and Kirschner, "Tau Protein Binds to Microtubules Through a Flexible Array of Distributed Weak Sites", J. Cell Biol 115: 717-730 (1991).
Drechsel et al., "Modulation of the Dynamic Instability of Tubulin Assembly by the Microtubule-Associated Protein Tau", Mol. Biol. Cell. 3: 1141-1154 (1992).
Goedert et al., "Expression of Separate Isoforms of Human Tau Protein: Correlation with the Tau Pattern in Brain and Effects on Tubulin Polymerization", Embo J. 9: 4225-4230 (1990).
Kosik et al., "Developmentally Regulated Expression of Specific Tau Sequences", Neuron 2: 1389-1387 (1989).
Lee et al., "Tau Proteins are Abnormally Expressed in Olfactory Epithelium of Alzheimer Patients and Developmentally Regulated in Human Fetal Spinal Cord", Experimental Neurology 121: 93-105 (1993).
Lindwall et al., "Phosphorylation Affects the Ability of Tau Protein to Promote Microtubule Assembly", J. Biol. Chem. 259: 5301-5305 (1984).
Murthy et al., "Microtubule Assembly Using the Microtubule-Associated Protein MAP-2 Prepared in Defined States of Phosphorylation with Protein Kinase and Phosphatase", Eur. J. Biochem. 137: 37-46 (1983).
Schiff et al. "Promotion of Microtubule Assembly in Vitro by Taxol", Nature 277: 665-667 (1979).
Trojanowski et al., "Altered Tau and Neurofiliament Proteins in NeuroDegenerative Diseases: Diagnostic Implications for Alzheimer's Disease and Lewy Body Dementias", Brain Pathol.3:45-54 (1993).
Vallee, "A Taxol-Dependent Procedure for the Isolation of Microtubles and Microtubule-Associated Proteins (MAPs)", J. Cell Biol. 92: 435-442 (1982).
Williams and Detrich, "Separation of Tubulin from Microtubule-Associated Proteins on Phosphocellulose. Accompanying Alterations in Concentrations of Buffer Components", Biochemistry 18: 2499-2503 (1979).
Lee Virginia M-Y.
Trojanowski John Q.
Lilling Herbert J.
The Trustees of the University of Pennsylvania
LandOfFree
Method of stabilizing microtubules does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of stabilizing microtubules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of stabilizing microtubules will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-786035